SOX2 promotes tumorigenicity and inhibits the differentiation of I-type neuroblastoma cells

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 317-323

  Yang, Shaobo ^a   Zheng, Jicui ^a   Xiao, Xianmin ^a   Xu, Ting ^a   Tang, Weitao ^a   Zhu, Haitao ^a   Yang, Lin ^a   Zheng, Shan ^a   Dong, Kuiran ^a   Zhou, Guomin ^a   Wang, Yang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Differentiation; I type; Neuroblastoma; SOX2; Tumorigenicity

Indexed keywords

SMALL INTERFERING RNA; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; MALE; MOUSE; NEUROBLASTOMA; NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEUROBLASTOMA; RNA, SMALL INTERFERING; SOXB1 TRANSCRIPTION FACTORS;

EID: 84917740493     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2713     Document Type: Article

References (29)

1. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007.
2. Cohn SL, Pearson AD, London WB, et al: The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27: 289-297, 2009.
3. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
4. Gonzalez-Sarmiento R and Perez-Losada J: Breast cancer, a stem cell disease. Curr Stem Cell Res Ther 3: 55-65, 2008.
5. Atlasi Y, Mowla SJ, Ziaee SA and Bahrami AR: OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120: 1598-1602, 2007.
6. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007.
7. Ailles LE and Weissman IL: Cancer stem cells in solid tumors. Curr Opin Biotechnol 18: 460-466, 2007.
8. Komuro H, Saihara R, Shinya M, et al: Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines. J Pediatr Surg 42: 2040-2045, 2007.
9. Ross RA and Spengler BA: Human neuroblastoma stem cells. Semin Cancer Biol 17: 241-247, 2007.
10. Ross RA, Biedler JL and Spengler BA: A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett 197: 35-39, 2003.
11. Ciccarone V, Spengler BA, Meyers MB, Biedler JL and Ross RA: Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49: 219-225, 1989.
12. Ross RA, Spengler BA, Domenech C, et al: Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 6: 449-456, 1995.
13. Walton JD, Kattan DR, Thomas SK, et al: Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 6: 838-845, 2004.
14. Sinclair AH, Berta P, Palmer MS, et al: A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346: 240-244, 1990.
15. Kamachi Y, Uchikawa M and Kondoh H: Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 16: 182-187, 2000.
16. Xiang R, Liao D, Cheng T, et al: Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer 104: 1410-1417, 2011.
17. Ji J and Zheng PS: Expression of Sox2 in human cervical carcinogenesis. Hum Pathol 41: 1438-1447, 2010.
18. Fang X, Yu W, Li L, et al: ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers. OMICS 14: 369-384, 2010.
19. Gen Y, Yasui K, Zen Y, et al: SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma. Cancer Genet Cytogenet 202: 82-93, 2010.
20. Nakatsugawa M, Takahashi A, Hirohashi Y, et al: SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest 91: 1796-1804, 2011.
21. Lu Y, Futtner C, Rock JR, et al: Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One 5: e11022, 2010.
22. Yang S, Zheng J, Ma Y, et al: Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy. Oncol Rep 28: 186-192, 2012.
23. Melone MA, Giuliano M, Squillaro T, et al: Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients. Cancer Biol Ther 8: 1300-1306, 2009.
24. Cui H, Ma J, Ding J, et al: Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J Biol Chem 281: 34696-34704, 2006.
25. Zheng J, Xiao X, Liu J, et al: Growth-promoting effect of environmental endocrine disruptors on human neuroblastoma SK-N-SH cells. Environ Toxicol Pharmacol 24: 189-193, 2007.
26. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
27. Hansford LM, McKee AE, Zhang L, et al: Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 67: 11234-11243, 2007.
28. Tong QS, Zheng LD, Tang ST, et al: Expression and clinical significance of stem cell marker CD133 in human neuroblastoma. World J Pediatr 4: 58-62, 2008.
29. Jori FP, Galderisi U, Piegari E, et al: RB2/p130 ectopic gene expression in neuroblastoma stem cells: evidence of cell-fate restriction and induction of differentiation. Biochem J 360: 569-577, 2001.